Prachi Singh, DO, FAAP

Dr. Prachi Singh is a pediatric infectious disease specialist who cares for children with a wide variety of serious infections, including osteomyelitis (bone infection), complicated pneumonia, tuberculosis and coccidioidomycosis (also known as Valley fever). She sees patients in both the hospital and the clinic.

Singh has a special interest in antimicrobial stewardship, a program that promotes the appropriate use of antibiotics with a focus on reducing such problems as the spread of drug-resistant infections. She serves as medical director of the antimicrobial stewardship program at UCSF Benioff Children's Hospital Oakland, where she collaborates with other subspecialists and pharmacists to ensure children receive timely and appropriate antimicrobial therapy.

Singh earned her Doctor of Osteopathic Medicine degree at Nova Southeastern University. She completed a residency in pediatrics at the University of South Florida and a fellowship in pediatric infectious diseases at UCSF Benioff Children's Hospital Oakland. She is a fellow of the American Academy of Pediatrics and member of the Pediatric Infectious Diseases Society.
Websites

  1. Aparicio C, Willis ZI, Nakamura MM, Wolf J, Little C, Maron GM, Sue PK, Anosike BI, Miller C, Bio LL, Singh P, James SH, Oliveira CR, PIDS Pediatric COVID-19 Therapies Task Force. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis. Journal of the Pediatric Infectious Diseases Society 2024. PMID: 38780125


  2. Willis ZI, Oliveira CR, Abzug MJ, Anosike BI, Ardura MI, Bio LL, Boguniewicz J, Chiotos K, Downes K, Grapentine SP, Hersh AL, Heston SM, Hijano DR, Huskins WC, James SH, Jones S, Lockowitz CR, Lloyd EC, MacBrayne C, Maron GM, Hayes McDonough M, Miller CM, Morton TH, Olivero RM, Orscheln RC, Schwenk HT, Singh P, Soma VL, Sue PK, Vora SB, Nakamura MM, Wolf J. Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce. Journal of the Pediatric Infectious Diseases Society 2024. PMID: 38339996


  3. Zhou GY, Penwill NY, Cheng G, Singh P, Cheung A, Shin M, Nguyen M, Mittal S, Burrough W, Spad MA, Bourne S, Bardach NS, Perito ER. Utility of illness symptoms for predicting COVID-19 infections in children. BMC pediatrics 2022. PMID: 36357876


  4. Vo A, Holmen J, Singh P. Neonatal Coccidioidomycosis: A Case Report. The Pediatric infectious disease journal 2022. PMID: 35895879


  5. Singh P, Holmen J. Multidrug-Resistant Infections in the Developing World. 2022. PMID: 34794671


  6. Singh P, Steurer MA, Cantey JB, Wattier RL. Hospital-level Antibiotic Use and Complexity of Care Among Neonates. Journal of the Pediatric Infectious Diseases Society 2020. PMID: 31879765


  7. Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, Kara T, Somers VK. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clinic proceedings 2020. PMID: 32376101


  8. Singh P, Lee BP. Recurrent Nontyphoidal Salmonella Bacteremia in a 3-Year Old Male. The Pediatric infectious disease journal 2018. PMID: 29613969